GO:0050857 positive regulation of antigen receptor-mediated signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050857 describes any process that activates or increases the frequency, rate or extent of signaling pathways initiated by cross-linking of an antigen receptor on a B or T cell.
• Antigen receptor signaling is initiated when the T cell receptor (TCR) or B cell receptor (BCR) engages antigen, triggering phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) by Src-family kinases.
• The kinase Csk is a critical negative regulator that sets the threshold for antigen receptor signaling during T-lineage development and selection.
• Themis is a key positive regulator of TCR-mediated signaling that controls thymocyte selection.
• E3 ubiquitin ligases such as Cbl differentially regulate BCR-mediated signaling, shaping activation versus tolerance outcomes.
• Dysregulated lymphocyte antigen receptor signaling is associated with human immunodeficiency and immune dysregulation, including common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease.
Description
GO:0050857, positive regulation of antigen receptor-mediated signaling pathway, is a biological process term that captures any mechanism which activates or increases the frequency, rate or extent of signaling downstream of antigen receptor cross-linking on B or T lymphocytes. Antigen receptors are the sentinels of adaptive immunity: the T cell receptor (TCR) and B cell receptor (BCR) recognize processed antigen and initiate intracellular cascades that determine cell fate, from activation and proliferation to anergy or apoptosis. Because the strength, duration and quality of antigen receptor signals must be tightly controlled, positive regulators of this pathway are central to immune homeostasis and disease. Research into GO:0050857 spans immunology, signal transduction, and disease genetics. Positive regulation is achieved through kinases, adaptor proteins, ubiquitin-modifying enzymes, and membrane trafficking components that amplify or sustain receptor-proximal signals [5,6]. For example, the adaptor Themis positively regulates TCR-mediated signaling to control thymocyte selection, whereas the E3 ligase Cbl can differentially modulate BCR signaling outcomes. Conversely, the kinase Csk acts as a negative regulator that restrains antigen receptor signaling, and its loss alters T-lineage development. Dysregulation of these positive regulatory mechanisms contributes to immune pathology. Abnormal lymphocyte antigen receptor signaling has been documented in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease, and altered immune signaling is increasingly implicated in neurodegeneration. Understanding GO:0050857 therefore provides a framework for identifying therapeutic targets and biomarkers in immunology and beyond.
positive regulation of antigen receptor-mediated signaling pathway At A Glance
| GO ID | GO:0050857 |
|---|---|
| GO term | positive regulation of antigen receptor-mediated signaling pathway |
| Ontology | biological_process |
| Synonym | activation of antigen receptor-mediated signaling pathway; stimulation of antigen receptor-mediated signaling pathway; upregulation of antigen receptor-mediated signaling pathway |
| Major function | Increases the frequency, rate or extent of signaling initiated by antigen receptor cross-linking on B or T cells |
| Cell types involved | B lymphocytes and T lymphocytes |
| Receptor examples | T cell receptor (TCR), B cell receptor (BCR) |
| Representative regulators | Themis, Cbl, Csk, Src-family kinases, E3 ligases and deubiquitinases |
| Disease relevance | Immunodeficiency, immune dysregulation, neurodegeneration-associated immune signaling |
What Is GO:0050857?
In our own words, GO:0050857 refers to any biological process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B or T cell. It encompasses molecular events that positively regulate the cascade from receptor engagement to downstream cellular responses, without being restricted to a single gene product or cell type.
Why Is positive regulation of antigen receptor-mediated signaling pathway Important in Cell Biology?
GO:0050857 is important because the positive regulation of antigen receptor signaling determines whether a lymphocyte becomes activated, tolerant, or apoptotic, and thereby shapes adaptive immune responses. Positive regulators such as Themis are required for thymocyte selection, while negative regulators such as Csk set signaling thresholds during T-lineage development. E3 ubiquitin ligases and deubiquitinases dynamically reshape receptor-proximal signaling to fine-tune outcomes [5,6]. When these positive regulatory mechanisms are perturbed, immune deficiency and autoimmunity can result, as seen in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease. Moreover, immune signaling pathways are increasingly linked to neurodegeneration, underscoring the broad biomedical relevance of this GO term.
• Controls the threshold and amplitude of TCR and BCR signaling, influencing lymphocyte activation versus tolerance.
• Required for proper thymocyte selection through positive regulators such as Themis.
• Modulated by E3 ubiquitin ligases such as Cbl, which differentially regulate BCR-mediated signaling.
• Restrained by negative regulators such as Csk, which controls antigen receptor-mediated T-lineage development.
• Dysregulated in human immunodeficiency syndromes including CVID with GLILD.
• Implicated in immune signaling changes associated with neurodegeneration.
• Provides targets for immunomodulatory therapeutics in autoimmunity and cancer.
• Serves as a model for studying signal amplification, feedback and crosstalk in immune cells.
• Relevant to vaccine design and adoptive cell therapy through modulation of receptor signaling strength.
• Enables mechanistic dissection of ubiquitin-dependent and kinase-dependent control of immune activation [5,6].
What Happens During positive regulation of antigen receptor-mediated signaling pathway?
Receptor engagement and ITAM phosphorylation
In simple terms: When an antigen receptor binds its target, enzymes add phosphate tags to the receptor's tails, starting the signal.
Antigen receptor signaling begins when the TCR or BCR engages antigen, leading to phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) by Src-family kinases. Positive regulation at this step increases the efficiency of ITAM phosphorylation and recruitment of downstream effectors. The kinase Csk acts as a negative regulator that restrains this initiation, and its loss alters T-lineage development and selection.
Adaptor recruitment and signalosome assembly
In simple terms: Adapter proteins gather signaling molecules into a hub that amplifies the message.
Phosphorylated ITAMs recruit adaptor proteins and kinases that assemble a signalosome, amplifying receptor-proximal signals. Themis is a positive regulator of TCR-mediated signaling that controls thymocyte selection, demonstrating how adaptor function can increase signaling output. E3 ligases and deubiquitinases also participate in reshaping these complexes to sustain or modify signaling.
Ubiquitin-dependent modulation
In simple terms: Tagging proteins with ubiquitin can either boost or brake the signal, depending on the tag.
Ubiquitination and deubiquitination dynamically regulate antigen receptor signaling. The E3 ubiquitin ligase Cbl differentially regulates BCR-mediated signaling, influencing activation outcomes. E3 ligases and DUBs are also implicated in the initiation of TCR-mediated signaling and response, highlighting their role in positive regulation.
Kinase and phosphatase balance
In simple terms: Kinases add phosphates to push the signal forward, while phosphatases remove them to slow it down.
The balance between kinases and phosphatases determines the strength and duration of antigen receptor signals. Csk is a kinase that negatively regulates Src-family kinases, thereby controlling antigen receptor-mediated development and selection of T-lineage cells. Positive regulators counteract such brakes to sustain signaling.
Downstream transcriptional and functional outcomes
In simple terms: The amplified signal reaches the nucleus and changes gene expression, leading to cell activation or tolerance.
Sustained positive regulation leads to activation of transcription factors, changes in gene expression, and functional outcomes such as proliferation, cytokine production, or apoptosis. Dysregulation of these outcomes is observed in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease, where lymphocyte antigen receptor signaling is abnormal. Immune signaling changes are also linked to neurodegeneration.
Key Genes Involved in GO:0050857 positive regulation of antigen receptor-mediated signaling pathway
The following genes and proteins are representative positive or context-dependent regulators of antigen receptor-mediated signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Themis | Positive regulator of TCR-mediated signaling; controls thymocyte selection | Key model for studying positive regulation of TCR signaling |
| Cbl | E3 ubiquitin ligase that differentially regulates BCR-mediated signaling | Target for understanding ubiquitin control of BCR signaling |
| Csk | Negative regulator of Src-family kinases; controls antigen receptor-mediated T-lineage development | Defines signaling thresholds in T cell development |
| Src-family kinases (e.g., Lck, Fyn) | Phosphorylate ITAMs to initiate antigen receptor signaling | Core kinases in TCR/BCR signal initiation |
| ZAP-70 | Kinase recruited to phosphorylated ITAMs; amplifies TCR signaling | Central node in TCR signalosome |
| Syk | Kinase that transduces BCR signals | Key BCR signaling effector |
| LAT | Adaptor protein that nucleates the TCR signalosome | Scaffold for positive regulation |
| SLP-76 | Adaptor protein in TCR signaling | Component of signal amplification |
| PI3K | Lipid kinase that promotes downstream signaling | Modulates signal strength and duration |
| Akt | Serine/threonine kinase downstream of PI3K | Effector of positive regulation |
| NF-kB components | Transcription factors activated by antigen receptor signaling | Readout of pathway activation |
| NFAT | Transcription factor activated by calcium signaling | Functional readout of TCR/BCR activation |
| AP-1 | Transcription factor complex activated downstream of antigen receptors | Integrates signaling with gene expression |
| Nrf2 | Transcription factor linked to immune signaling and oxidative stress | Context-dependent modulator |
| Sestrin2 | Stress-inducible protein regulated by immune signaling | Example of downstream target |
| Toll-like receptor adaptors (e.g., MyD88) | Shared signaling components with antigen receptor pathways | Crosstalk with innate immune signaling |
| DUBs (e.g., CYLD, A20) | Deubiquitinases that reshape antigen receptor signaling | Regulate signal duration and outcome |
How Is positive regulation of antigen receptor-mediated signaling pathway Regulated?
Positive regulation of antigen receptor-mediated signaling is itself tightly regulated by kinases, phosphatases, ubiquitin ligases, and deubiquitinases. Csk restrains Src-family kinases to set signaling thresholds during T-lineage development. E3 ubiquitin ligases such as Cbl differentially regulate BCR signaling, and DUBs counteract ubiquitination to sustain or modify signaling. Toll-interleukin 1 receptor signaling components can also modulate immune signaling crosstalk, and transcription factors such as AP-1 and Nrf2 regulate downstream stress and immune responses.
positive regulation of antigen receptor-mediated signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Themis | T cell selection and immunodeficiency | Themis knockout or knock-in mouse models |
| Cbl | B cell signaling dysregulation and autoimmunity | Cbl knockout B cell lines |
| Csk | T-lineage developmental defects | Csk conditional knockout mice |
| CVID-associated genes | Common variable immunodeficiency with GLILD | Patient-derived lymphocytes and CRISPR-edited cell lines |
| Immune signaling genes | Neurodegeneration-associated immune dysfunction | Microglia or lymphocyte co-culture models |
Immunodeficiency and immune dysregulation
Dysregulated lymphocyte antigen receptor signaling is a feature of common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease, where abnormal signaling contributes to immune dysfunction. Positive regulators of antigen receptor signaling are therefore candidate modifiers of immunodeficiency phenotypes.
Neurodegeneration and immune signaling
Immune signaling pathways, including those downstream of antigen receptors, are increasingly implicated in neurodegeneration. Altered immune cell signaling may contribute to neuroinflammatory processes in degenerative diseases.
Autoimmunity and cancer
Because positive regulation of antigen receptor signaling determines activation versus tolerance, its dysregulation can promote autoimmunity or, conversely, impair anti-tumor immunity. E3 ligases and DUBs that modulate these pathways are potential therapeutic targets [5,6].
From positive regulation of antigen receptor-mediated signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene positively regulate TCR signaling? | Knockout T cell line or primary T cells |
| Does a point mutation alter signaling threshold? | Point-mutation knock-in cell model |
| Does a fusion tag affect signalosome assembly? | Tagged knock-in of the gene of interest |
| Does overexpression amplify antigen receptor signaling? | Overexpression cell model |
| Which genes modulate BCR signaling? | CRISPR library screening in B cell lines |
| What is the transcriptional output of positive regulation? | RNA-seq after receptor stimulation |
How to Study the positive regulation of antigen receptor-mediated signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-flow cytometry | Phosphorylation of signaling proteins | Quantify TCR/BCR signal strength |
| Immunoblotting | Protein phosphorylation and ubiquitination | Validate signaling changes |
| CRISPR knockout screening | Gene requirement for signaling | Identify positive regulators |
| RNA-seq | Transcriptional output | Measure downstream gene expression |
| Proteomics | Protein interactions and modifications | Map signalosome components |
| Calcium imaging | Calcium flux | Assess receptor-proximal signaling |
| Flow cytometry | Activation markers and proliferation | Functional readout of signaling |
| Co-immunoprecipitation | Protein complex formation | Study adaptor recruitment |
Phospho-proteomics and signaling assays
Phospho-specific antibodies and mass spectrometry can quantify ITAM phosphorylation and downstream kinase activation after receptor cross-linking, providing direct readouts of positive regulation [5,6].
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify positive regulators of antigen receptor signaling by selecting for cells with altered activation or survival after receptor stimulation.
Transcriptomics and functional genomics
RNA-seq and single-cell transcriptomics reveal gene expression changes downstream of antigen receptor signaling, including activation of NF-kB, NFAT, and AP-1 target genes [4,8].
Imaging and flow cytometry
Live-cell imaging and flow cytometry measure calcium flux, receptor clustering, and signalosome assembly to assess positive regulation in real time.
How CRISPR Can Be Used to Study GO:0050857 positive regulation of antigen receptor-mediated signaling pathway
Knockout
CRISPR knockout of candidate positive regulators such as Themis or Cbl can test their requirement for antigen receptor signaling and downstream selection outcomes [2,6].
Point Mutation
Point-mutation knock-in can model disease-associated variants in signaling genes and assess their impact on pathway activity.
Knock-in
Tagged knock-in of signaling proteins enables visualization and biochemical isolation of receptor-proximal complexes.
Overexpression
Overexpression of positive regulators can amplify antigen receptor signaling and reveal gain-of-function phenotypes in immune cells.
How EDITGENE Supports positive regulation of antigen receptor-mediated signaling pathway Research
Researchers studying positive regulation of antigen receptor-mediated signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activation, and to dissect the precise step at which it acts. EDITGENE provides the CRISPR tools and cell models required for such mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of antigen receptor-mediated signaling pathway research.
Frequently Asked Questions About positive regulation of antigen receptor-mediated signaling pathway
What is GO:0050857?
GO:0050857 is the Gene Ontology term for positive regulation of antigen receptor-mediated signaling pathway, describing any process that increases signaling initiated by antigen receptor cross-linking on B or T cells.
What genes are involved in positive regulation of antigen receptor-mediated signaling?
Key genes include Themis, Cbl, Csk, Src-family kinases, ZAP-70, Syk, and various E3 ligases and deubiquitinases [2,5,6,7].
How is antigen receptor signaling positively regulated?
Positive regulation occurs through kinases that phosphorylate ITAMs, adaptors that assemble signalosomes, and ubiquitin-modifying enzymes that sustain signaling [5,6].
What diseases are linked to dysregulated antigen receptor signaling?
Common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease and neurodegeneration-associated immune dysfunction are linked to altered antigen receptor signaling [3,8].
What is the role of Themis in TCR signaling?
Themis positively regulates TCR-mediated signaling and controls thymocyte selection.
How does Cbl regulate BCR signaling?
Cbl is an E3 ubiquitin ligase that differentially regulates B cell receptor-mediated signaling.
What is the role of Csk in T cell development?
Csk negatively regulates Src-family kinases and controls antigen receptor-mediated development and selection of T-lineage cells.
How can I study positive regulation of antigen receptor signaling?
CRISPR knockout, point mutation, knock-in, overexpression, phospho-flow, and CRISPR screening are common approaches [5,6].
What cell models are used for antigen receptor signaling research?
T and B cell lines, primary lymphocytes, and CRISPR-edited cells are widely used [2,5,8].
Why is GO:0050857 important for immunology?
It defines the mechanisms that amplify antigen receptor signals, which determine lymphocyte activation, tolerance, and immune responses [2,5,7].
Conclusion
GO:0050857 provides a structured framework for understanding how antigen receptor signaling is positively regulated in B and T cells. Key regulators such as Themis, Cbl, and Csk illustrate the balance between amplification and restraint that shapes immune outcomes [2,6,7]. Dysregulation of these mechanisms is linked to immunodeficiency and immune-related neurodegeneration [3,8]. CRISPR-based models and screening approaches offer powerful tools to dissect these pathways and identify therapeutic targets.
References
- 1. Li X et al.. 2005. Modulation of Toll-interleukin 1 receptor mediated signaling.. J Mol Med (Berl) 83(4):258-66 PMID: 15662540
- 2. Fu G et al.. 2009. Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling.. Nat Immunol 10(8):848-56 PMID: 19597499
- 3. Latour YL et al.. 2026. Immune signaling and function in neurodegeneration.. J Clin Invest 136(8) PMID: 41983391
- 4. Kim MG et al.. 2015. Regulation of Toll-like receptor-mediated Sestrin2 induction by AP-1, Nrf2, and the ubiquitin-proteasome system in macrophages.. Toxicol Sci 144(2):425-35 PMID: 25637945
- 5. Cammann C et al.. 2022. Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response.. Int J Mol Sci 23(7) PMID: 35408787
- 6. Shao Y et al.. 2004. Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl.. J Biol Chem 279(42):43646-53 PMID: 15304502
- 7. Schmedt C et al.. 1998. Csk controls antigen receptor-mediated development and selection of T-lineage cells.. Nature 394(6696):901-4 PMID: 9732874
- 8. Lui VG et al.. 2023. Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease.. J Clin Immunol 43(6):1311-1325 PMID: 37093407
